CARRIE MCKIERNON: Open Payments
NPI 1821307349 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 24 payments from 9 companies in 2025. Trend: 2023 $516 · 2024 $625 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $246 |
| Kite Pharma, Inc. | 8 | $207 |
| Celgene Corporation | 7 | $157 |
| BeOne Medicines USA, Inc. | 1 | $105 |
| Legend Biotech USA Inc. | 1 | $48 |
| CARDIVA MEDICAL, INC. | 1 | $30 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: BREYANZI, Yescarta, BRUKINSA, REBLOZYL, CARVYKTI, OPTOWIRE, XPOVIO, JAKAFI.
Industry payments across MS — which companies pay providers there.
